潍坊亚星化学股份有限公司 关于终止公司发行股份及支付现金购买资产并募集配套资 金暨关联交易事项相关人员买卖股票情况 自查报告的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600319 证券简称：亚星化学 公告编号：临 2026-007 潍坊亚星化学股份有限公司（以下简称"公司"）于2026年1月13日召开第 九届董事会第二十一次会议，审议通过了《关于终止公司发行股份及支付现金购 买资产并募集配套资金暨关联交易的议案》，同意公司终止本次发行股份及支付 现金购买资产并募集配套资金暨关联交易事项,具体情况详见公司披露的《关于 终止公司发行股份及支付现金购买资产并募集配套资金暨关联交易的公告》（公 告编号：临2026-003）。 根据《上市公司重大资产重组管理办法》《监管规则适用指引——上市类第 1 号》《上海证券交易所上市公司自律监管指引第6号——重大资产重组》等法 律法规及规范性文件的规定，公司对本次交易相关内幕信息知情人买卖公司股票 的情况进行了核查。具体情况如下： 一、本次交易的内幕信息知情人自查期间 本次 ...

Core Viewpoint - The company, Yaxing Chemical, announced the termination of its plan to issue shares and pay cash for asset acquisition along with related fundraising and transactions on January 13, 2026 [1] Group 1: Self-Examination Findings - The self-examination period was from November 18, 2025, to January 13, 2026, covering the company and relevant parties involved [1] - During the self-examination, it was found that CITIC Securities' proprietary trading account bought a total of 348,500 shares and sold 357,300 shares, resulting in a closing balance of 0 shares [1] - An individual named Zheng Mingliang bought 4,500 shares on December 30-31, 2025, and sold them on January 6, 2026, with both parties claiming that their transactions were unrelated to the restructuring [1] Group 2: Conclusion of Self-Examination - The conclusion of the self-examination indicated that the trading activities of the relevant parties and individuals did not constitute insider trading [1]

Group 1 - The core viewpoint of the article indicates that Yaxing Chemical (600319) is expected to report a net profit loss of between 145 million to 174 million yuan for 2025, with a significant increase in losses compared to the same period in 2024 [1][2] - The company's main business continues to face pressure, with a gross profit margin of -2.29% and a net profit margin of -22.52% reported for Q3 2025, alongside a rising debt-to-asset ratio of 85.15% and a current ratio of only 0.26, indicating significant short-term repayment pressure [1] - The new materials project, although in trial production by the end of 2025, has not yet contributed to the annual performance, and the effectiveness of the transformation remains to be observed [1][2] Group 2 - On February 13, 2026, Yaxing Chemical announced the termination of the planned acquisition of Shandong Tianyi Chemical due to differing demands among the parties involved [2] - The company's focus on new material projects, such as PVDC, is currently in the trial production phase, making it difficult to reverse the loss situation in the short term [2] - Over the past week (February 6 to 13, 2026), Yaxing Chemical's stock price experienced a fluctuation of 5.63%, closing at 8.02 yuan on February 13, with a single-day drop of 0.25% and low trading volume, as the turnover rate remained below 1% [3]

1、2026 年各银行综合授信情况 潍坊亚星化学股份有限公司 关于 2026 年度综合授信及提供抵押担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2026 年 1 月 30 日，潍坊亚星化学股份有限公司（以下简称"公司"）第九 届董事会第二十二次会议审议通过了《关于 2026 年度综合授信及提供抵押担保 的议案》,主要内容如下： 为了满足公司经营发展需要，公司或子公司 2026 年度拟向各银行申请合计 金额为人民币 5.305 亿元的综合授信额度，包括但不限于本外币资金贷款、银行 承兑汇票、国际或国内贸易融资等信用业务。经公司与银行协商，公司的部分授 信额度须以公司或子公司的资产向银行提供综合授信抵押担保。具体情况如下： | 序号 | 行 别 | 申请金额（亿元） | | --- | --- | --- | | 1 | 中国农业银行股份有限公司 | 1.90 | | 2 | 日照银行股份有限公司 | 1.50 | | 3 | 中国银行股份有限公司 | 1.16 | | 4 | 光大银行股份有限公司 | 0.50 ...

Group 1 - The core viewpoint of the article indicates that the company's production and operations are progressing normally, and new projects are advancing as planned [1] - The company has disclosed all operational information that is required, ensuring transparency in its business activities [1] - The competitive landscape for the company's main product, CPE, remains intense, posing significant competitive pressure [1] Group 2 - The company has timely disclosed the progress of several new projects, maintaining communication with stakeholders [1]

Group 1 - The core viewpoint of the article indicates that the company's production and operations are progressing normally, and new projects are advancing as planned [1] - The company has disclosed all operational information that is required, ensuring transparency in its activities [1] - The competitive landscape for the company's main product, CPE, remains intense, posing significant competitive pressure [1] Group 2 - The company has timely disclosed the progress of several new projects, maintaining communication with stakeholders [1]

Group 1 - The company, Yaxing Chemical, is currently in the trial production phase for its recently introduced products, which are still undergoing capacity ramp-up, product validation, and market promotion [2] - The progress of these projects is part of the company's routine operations and has not yet reached the disclosure standards required for public announcement [2]

Group 1 - The company, Yaxing Chemical (600319), has been exporting Chlorinated Polyethylene (CPE) to multiple countries and regions, including EU countries, for many years [1] - Currently, the revenue from CPE exports to the EU accounts for approximately 4% of the company's total operating income [1] - The company sells CPE in the EU market both directly to customers and through agents [1]

Core Viewpoint - The financial performance of Yaxing Chemical for 2024 shows significant losses, with a net profit attributable to shareholders of approximately -97.03 million yuan, primarily due to intensified market competition and low product prices [1] Group 1: Financial Performance - In 2024, Yaxing Chemical reported a total profit of -98.32 million yuan and a net profit attributable to shareholders of -97.03 million yuan, with a net profit excluding non-recurring gains and losses of about -156 million yuan [1] - The company received compensation of 46.74 million yuan for losses related to relocation, which will positively impact the net profit and net assets attributable to shareholders for 2025 [1] Group 2: Operational Insights - The company has seen steady progress in production and operations, with a continuous growth trend in the production and sales of its main products since the relocation [1] - Despite the ongoing development of new projects, including a 45,000-ton high-end new material (PVDC) project and other industrialization projects, these have not yet impacted the 2025 performance, which will still rely on existing product lines [1] Group 3: Strategic Developments - Yaxing Chemical has undergone significant ownership changes, with Shenzhen Changcheng Huili becoming the controlling shareholder in 2016, followed by a restructuring in 2022 that led to the Weifang City Investment Group acquiring control [4] - The company initiated a new PVDC material project in collaboration with South Korea's SK Group, which is expected to be operational by 2025 [4] - In 2026, Yaxing Chemical announced the termination of a major asset restructuring plan to acquire Shandong Tianyi Chemical, indicating a shift in strategic focus [4] Group 4: Market Performance - Despite the financial struggles, Yaxing Chemical's stock price saw a remarkable increase of 93.3% in 2025, contrasting sharply with the company's ongoing losses [4] - For the first three quarters of 2025, the company reported a net profit loss of 144 million yuan, highlighting the disparity between market performance and financial health [4]

Core Viewpoint - Wefang Yaxing Chemical Co., Ltd. anticipates a significant net loss for the fiscal year 2025, continuing the trend of losses from the previous year [2][3] Group 1: Performance Forecast - The company expects a net profit attributable to shareholders to be between -174 million yuan and -145 million yuan for 2025, indicating continued losses compared to the previous year [2][3] - The forecasted net profit, excluding non-recurring gains and losses, is projected to be between -234 million yuan and -195 million yuan, also reflecting ongoing losses [2][3] Group 2: Previous Year Performance - In the previous year, the total profit was -98.32 million yuan, with a net profit attributable to shareholders of -97.03 million yuan, and a net profit excluding non-recurring gains and losses of -155.84 million yuan [5] Group 3: Reasons for Expected Loss - The decline in main business performance is attributed to intensified market competition, leading to low product prices and reduced gross margins [7] - Although new projects such as the high-end material (PVDC) and other industrialization projects have begun trial production, they have not yet impacted the 2025 performance significantly [7] - Increased financial costs due to higher funding needs for both operations and new project construction are also contributing to the expected decline in net profit [7] Group 4: Non-Operating Gains - The company received compensation of 46.74 million yuan for losses related to relocation and downtime, which will positively impact the net profit and net assets for 2025 [8]